文献速递基础与转化研究新药、器械与细胞基因治疗研发

ZAP327信号域驱动的嵌合抗原受体在小鼠模型中产生强效且长期的抗肿瘤免疫

ZAP327 signaling domain-driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models.
PubMed 文献 · Sci Transl Med · 2025-12-10

研究构建了含ZAP70来源信号域(ZAP327)的嵌合抗原受体(CAR),在小鼠模型中ZAP327 CAR T细胞减少细胞因子释放和耗竭标志物表达,保持或增强细胞毒活性,体内T细胞持久性增加,在抗原低表达肿瘤模型中优于传统及多种改进型CAR T细胞。

要点

  • ZAP327 CAR T细胞减少细胞因子释放和T细胞耗竭标志物表达,维持相似或更好的细胞毒活性。
  • CD28和4-1BB共刺激域为ZAP327激酶结构域提供间隔区,对最佳折叠和功能及共刺激信号是必需的。
  • ZAP327 CAR T细胞在抗原低表达肿瘤模型中优于传统和多种近期改进的CAR T细胞。

核心结论

  • ZAP327驱动的CAR T细胞具有克服当前CAR T细胞疗法局限性的治疗潜力,并增强实体瘤中抗肿瘤T细胞反应的效力和持久性。

研究设计与样本

  • 研究在小鼠模型中构建并比较了含ZAP70来源信号域(ZAP327)的CAR T细胞与传统CAR T细胞及多种近期改进的CAR T细胞。

主要发现

  • ZAP327驱动的CAR T细胞减少细胞因子释放和T细胞耗竭标志物表达,但维持与常规CAR T细胞相似或更好的抗肿瘤细胞毒活性。
  • ZAP327 CAR构建体中的CD28和4-1BB共刺激域为跨膜域与ZAP327激酶域之间提供间隔区,对最佳激酶结构折叠和功能以及共刺激信号是必需的。
  • ZAP327驱动的CAR T细胞在治疗性抗肿瘤免疫中优于传统和几种近期改进的CAR T细胞,尤其在抗原低表达肿瘤模型中。
  • 机制上,ZAP327域下调TCR信号,增加干细胞样记忆T细胞池,并通过氧化磷酸化途径表现出与记忆T细胞相关的代谢特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chimeric antigen receptor (CAR) T cell therapy has shown impressive clinical responses in the treatment of blood cancers, but high percentages of disease relapse 1 year after T cell infusion and severe toxicities associated with CAR T cell therapy remain major issues. Here, we report the construction of CARs with a ZAP70-derived signaling domain (ZAP327) that enhances therapeutic antitumor activity with increasing in vivo T cell persistence. ZAP327-driven CAR T cells reduced cytokine release and expression of T cell exhaustion markers but maintained similar or better cytolytic activity against tumor cells compared with conventional CAR T cells. The costimulatory domains, such as CD28 and 4-1BB, in the ZAP327 CAR constructs are required for providing a spacer between the transmembrane domain and ZAP327 kinase domain for optimal kinase structure folding and function, as well as costimulatory signaling. Furthermore, ZAP327-driven CAR T cells outperform conventional and several recently improved CAR T cells in therapeutic antitumor immunity, particularly in an antigen-low expression tumor model, which is clinically relevant and important for immune escape and disease relapse. Mechanistically, we show that the ZAP327 domain tuned down TCR signaling, increased the pools of stem-like memory T cells, and exhibited metabolic features associated with memory T cells by using the oxidative phosphorylation pathway. These results highlight the therapeutic potential of ZAP327-driven CAR T cells to overcome the limitations of the current CAR T cell therapies and enhance the potency and persistence of antitumor T cell responses in solid tumors as well.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Liu X, Zhang J, Chu J, et al. ZAP327 signaling domain-driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models. Sci Transl Med. 2025. PMID: 41370403. doi:10.1126/scitranslmed.adz0529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。